Literature DB >> 2937840

Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.

M Akasaki, P Jardieu, K Ishizaka.   

Abstract

Glycosylation inhibiting factor (GIF) was purified from culture filtrates of a T cell hybridoma, 23A4, by affinity chromatography on anti-lipomodulin Sepharose. The factor exhibited phospholipase inhibitory activity upon dephosphorylation. Immunization of BDF1 mice with aluminum hydroxide gel (alum)-absorbed dinitrophenyl derivatives of ovalbumin (DNP-OA) resulted in persistent IgE and IgG antibody formation. However, repeated injections of the affinity-purified GIF into the DNP-OA-primed mice beginning on the day of priming prevented the primary anti-hapten antibody responses of both the IgE and the IgG1 isotypes. Treatment with GIF also diminished on-going IgE antibody formation in the DNP-OA-primed mice. The treatment changed the nature of IgE-binding factors formed by BDF1 spleen cells. Incubation of spleen cells from OA + alum-primed mice with OA resulted in the formation of IgE-potentiating factor, whereas spleen cells of OA-primed, GIF-treated mice formed IgE-suppressive factor upon antigenic stimulation. It was also found that Lyt-2+ T cells in the OA-primed, GIF-treated mouse spleen cells released GIF, which had affinity for OA and bore I-Jb determinant(s). Transfer of a Lyt-1+ cell-depleted fraction of the OA-primed, GIF-treated mouse spleen cells into naive syngeneic animals resulted in suppression of the primary anti-DNP IgE antibody response of the recipients to alum-absorbed DNP-OA, but failed to affect the anti-DNP antibody response to DNP-keyhole limpet hemocyanin. The results indicate that GIF treatment during the primary response to OA facilitated the generation of antigen-specific suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937840

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Glycosidase activities in alveolar macrophages from guinea pigs stimulated with a glyco-proteic complex extracted from Klebsiella pneumoniae.

Authors:  M M Briend-Sutren; S Le Maho; M Rommain; C R Lambré
Journal:  Agents Actions       Date:  1990-11

2.  Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.

Authors:  Y Ishii; T Nakano; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Biochemical identification of glycosylation inhibiting factor.

Authors:  K Katamura; M Iwata; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Potentiating and suppressive IgE-binding factors are expressed by a single cloned gene.

Authors:  C L Martens; P Jardieu; M L Trounstine; S G Stuart; K Ishizaka; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

Review 5.  Genetic control of IgE immune response.

Authors:  S Matsushita; T Sasazuki
Journal:  Clin Rev Allergy       Date:  1989

6.  Enzyme immunoassays for specific IgG and IgE antibodies to Pichia pastoris components in normal humans.

Authors:  W Ohtani; K Kobayashi; T Ohmura
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

7.  Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.

Authors:  T Mikayama; T Nakano; H Gomi; Y Nakagawa; Y C Liu; M Sato; A Iwamatsu; Y Ishii; W Y Weiser; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  The role of complement component C3b and its receptors in sperm-oocyte interaction.

Authors:  D J Anderson; A F Abbott; R M Jack
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis.

Authors:  C R Lambré; Y Pilatte; S Le Maho; A Greffard; H De Crémoux; J Bignon
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

10.  Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.

Authors:  Y C Liu; T Nakano; C Elly; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.